🔎 Trials Near Me

Dachaigh › Siostam Immune agus Galaran › Missouri

Sgrùdaidhean clionaigeach Siostam Immune agus Galaran ann an Missouri

Tha 6 sgrùdaidhean airson Siostam Immune agus Galaran a’ lorg phàirtichean aig làraichean ann an Missouri.

Bailtean ann an Missouri

Teacsa sgrùdaidh oifigeil (Beurla)

A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma

  • Washington University School of Medicine - Oncology Hospital - Public, St Louis
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 30 Sult 2026 · NCT07192471

A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia

  • MidAmerica Cancer Center, Kansas City
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 18 Sult 2026 · NCT06722235

Collection of Research Data and Samples From Patients Treated With Immunotherapy to Study Its Side Effects

  • Mercy Oncology and Hematology - Clayton-Clarkson, Ballwin
  • Central Care Cancer Center - Bolivar, Bolivar
  • Cox Cancer Center Branson, Branson
  • agus 23 a bharrachd
A’ fastadhSgrùdadh amharc
Gach aois · Gach gnè · Air ùrachadh 17 Sult 2026 · NCT04242095

A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia

  • MidAmerica Cancer Center, Kansas City
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 9 Sult 2026 · NCT06948318

Reduced Intensity Conditioning and Familial HLA-Mismatched BMT for Non-Malignant Disorders

  • Washington University School of Medicine, St Louis
A’ fastadhÌre 1/2
1 Day – 21 Years · Gach gnè · Air ùrachadh 29 Cèit 2026 · NCT03128996

A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)

  • Washington University School of Medicine - Siteman Cancer Center, St Louis
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 15 Dùbh 2025 · NCT06619561

Bho ClinicalTrials.gov, dàta air a thogail 5 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.